Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore requiring analytical treatment interruption (ATI) in study participants. Little is known about the safety of ATI and its long-term impact on patient health. OBJECTIVES: ATI safety was assessed and pot...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: De Scheerder, Marie-Angélique, Van Hecke, Clarissa, Zetterberg, Henrik, Fuchs, Dietmar, De Langhe, Nele, Rutsaert, Sofie, Vrancken, Bram, Trypsteen, Wim, Noppe, Ytse, Van Der Gucht, Bea, Pelgrom, Jolanda, Van Wanzeele, Filip, Palmer, Sarah, Lemey, Philippe, Gisslén, Magnus, Vandekerckhove, Linos
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869780/
https://ncbi.nlm.nih.gov/pubmed/32053203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi